微创二尖瓣手术中标准化瓣下修复治疗IIIb型功能性二尖瓣反流
本研究为前瞻性平行队列研究,比较在二尖瓣成形环基础上联合标准化瓣下修复(A组,n=60)与单纯成形环(B组,n=48)治疗伴双叶栓系征的IIIb型功能性二尖瓣反流。主要终点为术后1年死亡或复发MR>2,A组3.3%显著低于B组20.8%(P=0.037);总死亡率A组1.7%也低于B组12.5%(P=0.041)。微创入路下瓣下修复可行且围术期结果与开胸相当。
要点
- 联合瓣下修复较单纯成形环显著降低术后1年死亡或复发MR>2(3.3% vs 20.8%)。
- 联合瓣下修复组总死亡率更低(1.7% vs 12.5%)。
- 标准化乳头肌重排可经微创入路完成,围术期结果与开胸相当。
核心结论
- 标准化乳头肌重排经微创入路可行且可重复,围术期结果优异,较单纯成形环可显著降低MR复发并改善1年结局。
研究设计与样本
- 前瞻性平行队列研究,连续纳入108例伴严重双叶栓系征的IIIb型功能性MR患者,A组(成形环+瓣下修复)n=60,B组(单纯成形环)n=48。
- 主要终点为术后1年死亡或复发MR>2;次要终点为生存和临床结局,特别关注微创治疗亚组。
主要发现
- 手术时间、体外循环时间和主动脉阻断时间两组相当。
- 围术期结果及超声心动图结局参数相似,且与入路(全内镜 vs 全胸骨切开)无关。
- 术后12个月随访,死亡或MR>2在A组为3.3%(2/60),B组为20.8%(10/48),P=0.037。
- 随访期间总死亡率A组为1.7%(1/60),B组为12.5%(6/48),P=0.041。
临床怎么用
- 对于伴双叶栓系征的IIIb型功能性MR,在成形环基础上考虑联合标准化瓣下修复以降低复发和死亡风险。
- 标准化瓣下修复可经微创入路实施,围术期安全性与开胸相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Subannular repair techniques in addition to undersized ring annuloplasty have been developed to address high mitral regurgitation (MR) recurrence rates after mitral valve repair in type IIIb MR. We compared the results of annuloplasty with simultaneous standardized subannular repair versus isolated annuloplasty, focusing on the periprocedural outcomes of minimally invasive procedures. METHODS: A consecutive series of 108 patients with type IIIb functional MR with severe signs of bileaflet tethering underwent an annuloplasty + subannular repair (group A; n = 60) versus isolated annuloplasty (group B; n = 48). The primary end point of this prospective, parallel cohort study was death or recurrent MR >2, 1 year postoperatively. The secondary end points were survival and clinical outcomes, with special regard for the minimally invasively treated subgroups. RESULTS: Duration of surgery, cardiopulmonary bypass time and aortic cross-clamp time were comparable between both study groups. Procedural outcomes as well as echocardiographic outcome parameters were similar and independent of access (fully endoscopic versus full sternotomy). At the 12-month follow-up, death or MR >2 occurred in 3.3% (2/60) of patients in group A vs in 20.8% (10/48) of patients in group B (P = 0.037). The overall mortality rate during the follow-up period was 1.7% (1/60) in group A vs 12.5% (6/48) in group B (P = 0.041). CONCLUSIONS: Standardized realignment of papillary muscles is feasible and reproducible via a minimally invasive approach, resulting in excellent periprocedural outcomes, and has a clear potential to significantly decrease MR recurrence and improve 1-year outcomes compared to isolated annuloplasty.
引用
- Pausch J, Harmel E, Sinning C, et al. Standardized subannular repair for type IIIb functional mitral regurgitation in a minimally invasive mitral valve surgery setting†. Eur J Cardiothorac Surg. 2019. PMID: 31005995. doi:10.1093/ejcts/ezz114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。